Skip to main content
Therapeutic Advances in Psychopharmacology logoLink to Therapeutic Advances in Psychopharmacology
. 2024 May 28;14:20451253241258536. doi: 10.1177/20451253241258536

Corrigendum to “Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series”

PMCID: PMC11131394  PMID: 38808099

Prasad F, De R, Korann V, et al. Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series. Ther Adv Psychopharmacol 2023;13. DOI:10.1177/20451253231165169

In above-mentioned article, Figure 2 only included the percentage change in weight from the baseline of 11 patients. Figure 2 should reflect this data for all 12 patients included in the case series.

The corrected version of Figure 2 is provided below:

graphic file with name 10.1177_20451253241258536-img1.jpg

The article has been corrected.


Articles from Therapeutic Advances in Psychopharmacology are provided here courtesy of SAGE Publications

RESOURCES